References
- Burlina S, Dalfra MG, Chilelli NC, et al. Gestational diabetes mellitus and future cardiovascular risk: an update. Int J Endocrinol. 2016;2016:2070926.
- Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018;61(6):1249–1260.
- Fetita LS, Sobngwi E, Serradas P, et al. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006;91(10):3718–3724.
- Group HSCR. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–459.
- Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–1868.
- McConnell BB, Yang VW. Mammalian kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–1381.
- Mreich E, Chen XM, Zaky A, et al. The role of kruppel-like factor 4 in transforming growth factor-beta-induced inflammatory and fibrotic responses in human proximal tubule cells. Clin Exp Pharmacol Physiol. 2015;42(6):680–686.
- Lee HY, Youn SW, Cho HJ, et al. FOXO1 impairs whereas statin protects endothelial function in diabetes through reciprocal regulation of kruppel-like factor 2. Cardiovasc Res. 2013;97(1):143–152.
- Yue W, Li Y, Ou D, et al. The GLP-1 receptor agonist liraglutide protects against oxidized LDL-induced endothelial inflammation and dysfunction via KLF2. IUBMB Life. 2019;71(9):1347–1354.
- Fathollahi A, Massoud A, Amirzargar AA, et al. sICAM-1, sVCAM-1 and sE-Selectin levels in type 1 diabetes. Fetal Pediatr Pathol. 2018;37(1):69–73.
- Gokulakrishnan K, Deepa R, Mohan V, et al. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome–the chennai urban rural epidemiology study. Metabolism. 2006;55(2):237–242.
- Matsumoto K, Nakamura H, Ueki Y, et al. Correction of hyperglycaemia reduces insulin resistance and serum soluble E-selectin levels in patients with type 2 diabetes mellitus. Diabet Med. 2001;18(3):224–228.
- Htwe TN, Thein OM, Hmone SW, University of Medicine 2, Yangon, et al. Prevalence of insulin receptor substrate-1 gene (G972R) polymorphism, insulin resistance, and determination of β-Cell function among overweight and obese persons with type 2 diabetes mellitus. JAFES. 2021;36(1):25–30.
- García-Claver A, Ramos-Corral R, Laviña-Fañanás C, et al. Capillary glucose concentration during oral glucose tolerance test for the diagnosis of gestational diabetes. Int J Gynaecol Obstet. 2020;150(2):234–240.
- Paracha AI, Haroon ZH, Aamir M, et al. Diagnostic accuracy of markers of insulin resistance (HOMA-IR) and insulin sensitivity (QUICKI) in gestational diabetes. J Coll Physicians Surg Pak. 2021;31(9):1015–1019.
- Xiao B, Tong C, Jia X, et al. Tyrosine replacement of PSGL-1 reduces association kinetics with P- and L-selectin on the cell membrane. Biophys J. 2012;103(4):777–785.
- Yngen M, Li N, Hjemdahl P, et al. Insulin enhances platelet activation in vitro. Thromb Res. 2001;104(2):85–91.
- Jubeli E, Moine L, Vergnaud-Gauduchon J, et al. E-selectin as a target for drug delivery and molecular imaging. J Control Release. 2012;158(2):194–206.
- Meigs JB, Hu FB, Perhanidis JS, et al. E-selectin genotypes and risk of type 2 diabetes in women. Obes Res. 2005;13(3):513–518.
- Zhito AV, Iusupova AO, Kozhevnikova MV, et al. E-Selectin as a marker of endothelial dysfunction in patients with coronary artery disease including those with type 2 diabetes mellitus. Kardiologiia. 2020;60(4):24–30.
- Gong J, Zhan H, Li Y, et al. Kruppellike factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway. Mol Med Rep. 2019;20(4):3240–3248.
- Chiplunkar AR, Curtis BC, Eades GL, et al. The kruppel-like factor 2 and kruppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis. BMC Dev Biol. 2013;13:40.
- Lin Z, Kumar A, SenBanerjee S, et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005;96(5):e48–e57.
- Xia Y, Feng H, Li ZW, et al. Low-dose phloretin alleviates diabetic atherosclerosis through endothelial KLF2 restoration. Biosci Biotechnol Biochem. 2020;84(4):815–823.